34 - Postinduction MRD identifies patients with NPM1 AML who benefit from allogeneic transplant
Вставка
- Опубліковано 11 вер 2024
- Discussão do artigo: "Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission " de Othman J Blood 2024
Apresentado por: Dra. Luana Pompeu
Discussão por: Dr. Rafael Faust, Dra. Camila Ferreira, Dr. Pedro Arruda e Dr. Vinicius Molla